BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2014

Position Statistics

Total Positions 78
New Positions 9
Increased Positions 36
Decreased Positions 25
Positions with Activity 61
Sold Out Positions 8
Total Mkt Value (in $ millions) 1,406

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.63%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.33%
Healthcare 86.87%
Services 0%
Technology
Transportation
Utilities

9 New Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) Change in Value ($1,000s) ▲ Change (%) Shares Held
RAPTOR PHARMACEUTICAL CORP COM 171 171 New 15,558
MASIMO CORP COM 3,342 3,342 New 97,900
ADMA BIOLOGICS INC COM 3,561 3,561 New 389,193
HEARTWARE INTL INC COM 4,021 4,021 New 50,000
AMARIN CORP PLC SPONS ADR NEW 5,205 5,205 New 2,233,746
PARATEK PHARMACEUTICALS INC COM 7,387 7,387 New 260,283
MEDGENICS INC COM NEW 9,358 9,358 New 1,025,000
AUSPEX PHARMACEUTICALS INC COM 10,068 10,068 New 100,000
LIGAND PHARMACEUTICALS INC COM NEW 17,084 17,084 New 199,000


Create your free portfolio